ING-008
Cardiometabolic (Obesity, MASH)
PreclinicalActive
Key Facts
About Innosphera Pharma
First‑in‑class oral GPR84 modulator for IPF with a lipid‑mimetic platform targeting fibrosis and metabolic disease.
View full company profileCardiometabolic (Obesity, MASH)
First‑in‑class oral GPR84 modulator for IPF with a lipid‑mimetic platform targeting fibrosis and metabolic disease.
View full company profile